Corient Private Wealth LLC

Position in GERN — Geron Corp

CIK 1948780 MIAMI, FL

Position in GERN

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$45,013

+$28,904 QoQ

Shares Held

35,167

+225.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#158

of 258 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names. GERN ranks #102 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	112,098	$55,682,439
2	IONS	Ionis Pharmaceuticals Inc	196,791	$15,603,558
3	HALO	Halozyme Therapeutics, Inc.	187,447	$14,671,476
4	KRYS	Krystal Biotech, Inc.	32,580	$12,109,008
5	TECH	BIO-TECHNE Corp	122,377	$8,645,935
6	REGN	Regeneron Pharmaceuticals, Inc.	13,758	$8,578,663
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,797	$7,163,610
8	CLDX	Celldex Therapeutics, Inc.	186,110	$6,925,153

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,013	35,167	+225.3%	Shares	Sole	2026-08-17
2026-03-31	$16,109	10,812	-69.6%	Shares	Sole	2026-05-15
2025-12-31	$47,014	35,617	+0.6%	Shares	Sole	2026-03-09
2025-09-30	$48,504	35,405	-4.6%	Shares	Sole	2025-11-14
2025-03-31	$58,993	37,103	-1.3%	Shares	Sole	2025-05-14
2024-12-31	$133,050	37,585	+58.7%	Shares	Sole	2025-02-10
2024-09-30	$107,548	23,689	+0.2%	Shares	Sole	2024-11-12
2024-06-30	$100,259	23,646	-55.9%	Shares	Sole	2024-08-13
2024-03-31	$176,774	53,568	-40.6%	Shares	Sole	2024-05-09
2023-12-31	$190,307	90,193	+15.3%	Shares	Sole	2024-02-09
2023-09-30	$165,777	78,197	+4.1%	Shares	Sole	2023-11-03
2023-06-30	$241,061	75,097	-2.6%	Shares	Sole	2023-08-10
2023-03-31	$167,300	77,097	+83.1%	Shares	Sole	2023-05-15
2022-12-31	$101,874	42,097	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.